Electromed Inc. (ELMD)
AMEX AMEX Primary Summary
Electromed: Some Short Term Gain But I Fear Long Term Pain
Electromed (ELMD) has delivered strong revenue growth and margin improvement, but faces a highly competitive, fragmented market for its SmartVest product. ELMD lacks a durable moat, with rivals like Tactile Medical and Baxter showing stronger brand recognition, technological advantages, and higher recent growth rates. Scientific evidence questions the comparative efficacy of HFCWO versus alternative airway clearance therapies, undermining the long-term growth thesis for SmartVest.
3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes
ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.
Here is Why Growth Investors Should Buy Electromed (ELMD) Now
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
Electromed Inc. (ELMD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Electromed Inc. ever had a stock split?
Electromed Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | James L. Cunniff CEO | AMEX Exchange | 285409108 CUSIP |
| US Country | 174 Employees | - Last Dividend | - Last Split | 13 Aug 2010 IPO Date |
Overview
Electromed, Inc. is a pioneering company focusing on the advancement, manufacturing, marketing, and sales of airway clearance therapy alongside related products leveraging high frequency chest wall oscillation (HFCWO) therapy. This innovative approach is pivotal in pulmonary care for patients across various age groups both within the United States and internationally. With a foundation laid in 1992 and headquartered in New Prague, Minnesota, Electromed, Inc. is dedicated to enhancing the quality of life for individuals suffering from compromised pulmonary function due to conditions such as bronchiectasis, cystic fibrosis, and neuromuscular diseases. The company primarily serves the home health care and institutional markets, reaching its customers through physicians, health care providers, and direct patient sales.
Products and Services
- SmartVest Airway Clearance System
- SmartVest SQL System
- SmartVest Connect
- Single Patient Use SmartVest and SmartVest Wrap
This is a flagship product designed by Electromed, Inc., providing an effective airway clearance therapy through the application of high frequency chest wall oscillation. The system is engineered for ease of use and comfort, addressing the needs of patients with compromised pulmonary functions.
This system encompasses an inflatable therapy garment, a programmable air pulse generator, and a patented single hose. This hose functions to deliver air pulses from the generator to the garment, facilitating effective delivery of airway clearance therapy to the patient.
Integrating wireless technology, SmartVest Connect offers a personalized HFCWO therapy management portal. This innovation supports improved monitoring and management of therapy, empowering patients with chronic pulmonary conditions to engage more actively in their treatment plans.
Specifically designed for the acute care setting, these products cater to health care providers offering a solution for effective airway clearance on a single-patient basis. They are intended to meet the urgent needs of patients in healthcare facilities.
